INCA

Rio de Janeiro, Rio de Janeiro 20231-050

0 studies enrolling now · 2 studies all time

What they study most

Colo-rectal Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma, Non Small Cell Lung Carcinoma

Studies at this site

• Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients — Running, not enrolling
• Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 — Completed